Medical research

Simple cooler preserves tuberculosis drugs, records doses

Tuberculosis, now largely controlled in the industrialized world, remains a stubbornly persistent killer in most of Africa, as well as parts of Asia and South America. The spread of multidrug-resistant strains of TB has slowed ...

Other

TB patient charged in Calif for not taking meds

(AP) -- Authorities in California took the unusual step of jailing and charging a tuberculosis patient who they say refused to take medication to keep his disease from becoming contagious.

Diseases, Conditions, Syndromes

S.Africa conducts trials for shorter TB treatment

South African researchers said Friday they were conducting medical trials to shorten the duration of tuberculosis treatment to make it easier for patients to complete the full regimen.

Diseases, Conditions, Syndromes

Drug-resistant TB blamed on Indian treatment flaws

(AP) -- India's inadequate government-run tuberculosis treatment programs and a lack of regulation of the sale of drugs that fight it are responsible for the spiraling number of drug-resistant cases that are difficult to ...

Diseases, Conditions, Syndromes

Indian experts probing 'untreatable' TB cases

The Indian government on Tuesday dispatched a team of medical experts to the financial capital, Mumbai, to assess reports of a handful of cases of apparently untreatable tuberculosis.

Diseases, Conditions, Syndromes

India reports new TB strain resistant to all drugs

Indian doctors have reported the country's first cases of "totally drug-resistant tuberculosis," a long-feared and virtually untreatable form of the killer lung disease.

Diseases, Conditions, Syndromes

Study suggests new way to ensure effectiveness of TB treatment

A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent ...

Diseases, Conditions, Syndromes

US urges shorter treatment for TB

US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.

page 9 from 12